SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
therapeutic 2,439 words KG: ent-gene-9f063e98
Contents

LRRK2-GBA Combination Therapy for Parkinson's Disease

🔬 Protein Info
Gene SymbolLRRK2
Full NameGBA Combination Therapy for Parkinson's Disease
Chromosome12q12
Protein TypeProtein
Amino Acids2527 aa
PathwaysMAPK
UniProt IDSearch UniProt
GeneCardsLRRK2
Human Protein AtlasLRRK2
Associated DiseasesAging, Als, Alzheimer, Alzheimer's disease, Amyotrophic Lateral Sclerosis
Known Drugs/CompoundsBIIB094, Cigarette Smoking, Environmental Toxicants, levodopa, LPS, LRRK2 inhibitors
Interactions6-OHDA, ACETYLCHOLINE, ACHE, Actin, AD, AKT
SciDEX HypothesesG2019S primarily raises baseline LRRK2 kinase acti
KG Connections2611 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74APOE Isoform Conversion Therapy
Score: 0.72Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72Lysosomal Positioning Dynamics Modulation
Score: 0.69

Related Analyses (30)

Astrocyte Reactivity Subtypes in Neurodegeneration
neurodegeneration · archivedAutophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · completedAPOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completedNeuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · completed

Related Experiments (30)

LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40GLP-1 Agonist Responder Prediction Study — Precision Medicin
clinical · proposed · Score: 0.40AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40MLCS Quantification in Parkinson's Disease
validation · proposed · Score: 0.40Sirtuin Pathway Dysfunction Validation in Parkinson's Diseas
clinical · proposed · Score: 0.40

Key Papers (1)

Randomized control trial of evaluation of Clemastine effects on visual
Clinical neurology and neurosu 2020

See Also (10)

LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 4 hypothesesLX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 4 hypothesesBEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 4 hypothesesA Phase 2 Double-Blind, Randomized, Placebo-Controlled
clinical · Pages share 3 hypothesesALA-enriched Nutrition for APOE4 Carriers with MCI (NCT
clinical · Pages share 3 hypotheses

Knowledge Graph (2 edges)

ent-gene-9f063e98 data_in benchmark_ot_ad_answer_key:LRRK2
benchmark_ot_ad_answer_key:LRRK2 data_in ent-gene-9f063e98

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

SciDEX — scidex.ai — Dashboard | Atlas

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)